Yigal Nochomovitz
Stock Analyst at Citigroup
(3.04)
# 1,271
Out of 5,134 analysts
312
Total ratings
43.55%
Success rate
0.55%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NBIX Neurocrine Biosciences | Maintains: Buy | $203 → $204 | $127.76 | +59.67% | 3 | Feb 12, 2026 | |
| KRYS Krystal Biotech | Maintains: Buy | $320 → $336 | $287.84 | +16.73% | 10 | Jan 12, 2026 | |
| ARDX Ardelyx | Maintains: Buy | $11 → $14 | $6.76 | +107.10% | 17 | Jan 9, 2026 | |
| STTK Shattuck Labs | Maintains: Neutral | $2 → $4 | $4.00 | - | 5 | Jan 6, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Neutral | $9 → $7 | $7.40 | -5.41% | 9 | Jan 6, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $33 → $36 | $22.95 | +56.86% | 2 | Jan 6, 2026 | |
| ARVN Arvinas | Upgrades: Buy | $10 → $15 | $11.45 | +31.00% | 11 | Jan 6, 2026 | |
| OLMA Olema Pharmaceuticals | Maintains: Buy | $21 → $60 | $22.62 | +165.25% | 3 | Dec 12, 2025 | |
| DRTS Alpha Tau Medical | Maintains: Buy | $8 → $7 | $7.46 | -6.17% | 1 | Dec 10, 2025 | |
| LGND Ligand Pharmaceuticals | Initiates: Buy | $270 | $187.51 | +43.99% | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $10.09 | +58.57% | 7 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $24 | $5.63 | +326.29% | 2 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $77 | $53.17 | +44.82% | 22 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $31 | $22.78 | +36.08% | 4 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $6 | $1.33 | +351.13% | 11 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $399 → $405 | $354.86 | +14.13% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $5.50 | +154.55% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $8 | $1.55 | +416.13% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $45 | $21.57 | +108.62% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $56 | $19.24 | +191.06% | 9 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $46 | $26.77 | +71.83% | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $15.68 | +155.10% | 6 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $20.04 | +244.31% | 9 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $22 | $23.07 | -4.64% | 17 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.2 → $1.9 | $1.32 | +43.94% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $51 | $20.34 | +150.74% | 9 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $52 | $13.04 | +298.77% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $7 | $17.88 | -60.85% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.02 | +345.54% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $35.55 | +54.71% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $14.91 | +121.33% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $30.76 | +88.56% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.70 | +723.53% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $1.43 | -16.08% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $1.45 | +37.93% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $5.15 | +55.34% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $2.84 | -64.79% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $4.49 | +679.51% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $20.18 | +559.07% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $3.88 | +312.37% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.34 | +646.27% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.71 | +603.81% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $6.75 | - | 14 | Sep 28, 2021 |
Neurocrine Biosciences
Feb 12, 2026
Maintains: Buy
Price Target: $203 → $204
Current: $127.76
Upside: +59.67%
Krystal Biotech
Jan 12, 2026
Maintains: Buy
Price Target: $320 → $336
Current: $287.84
Upside: +16.73%
Ardelyx
Jan 9, 2026
Maintains: Buy
Price Target: $11 → $14
Current: $6.76
Upside: +107.10%
Shattuck Labs
Jan 6, 2026
Maintains: Neutral
Price Target: $2 → $4
Current: $4.00
Upside: -
Arcturus Therapeutics Holdings
Jan 6, 2026
Maintains: Neutral
Price Target: $9 → $7
Current: $7.40
Upside: -5.41%
ACADIA Pharmaceuticals
Jan 6, 2026
Maintains: Buy
Price Target: $33 → $36
Current: $22.95
Upside: +56.86%
Arvinas
Jan 6, 2026
Upgrades: Buy
Price Target: $10 → $15
Current: $11.45
Upside: +31.00%
Olema Pharmaceuticals
Dec 12, 2025
Maintains: Buy
Price Target: $21 → $60
Current: $22.62
Upside: +165.25%
Alpha Tau Medical
Dec 10, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $7.46
Upside: -6.17%
Ligand Pharmaceuticals
Dec 9, 2025
Initiates: Buy
Price Target: $270
Current: $187.51
Upside: +43.99%
Nov 17, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $10.09
Upside: +58.57%
Nov 14, 2025
Maintains: Buy
Price Target: $25 → $24
Current: $5.63
Upside: +326.29%
Nov 12, 2025
Maintains: Buy
Price Target: $87 → $77
Current: $53.17
Upside: +44.82%
Nov 11, 2025
Maintains: Buy
Price Target: $33 → $31
Current: $22.78
Upside: +36.08%
Nov 10, 2025
Maintains: Buy
Price Target: $7 → $6
Current: $1.33
Upside: +351.13%
Nov 10, 2025
Maintains: Buy
Price Target: $399 → $405
Current: $354.86
Upside: +14.13%
Nov 5, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $5.50
Upside: +154.55%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $1.55
Upside: +416.13%
Oct 31, 2025
Maintains: Buy
Price Target: $52 → $45
Current: $21.57
Upside: +108.62%
Oct 29, 2025
Maintains: Buy
Price Target: $54 → $56
Current: $19.24
Upside: +191.06%
Oct 28, 2025
Maintains: Buy
Price Target: $27 → $46
Current: $26.77
Upside: +71.83%
Oct 20, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $15.68
Upside: +155.10%
Aug 11, 2025
Maintains: Buy
Price Target: $66 → $69
Current: $20.04
Upside: +244.31%
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $23.07
Upside: -4.64%
Aug 7, 2025
Maintains: Buy
Price Target: $1.2 → $1.9
Current: $1.32
Upside: +43.94%
Aug 5, 2025
Maintains: Buy
Price Target: $46 → $51
Current: $20.34
Upside: +150.74%
Aug 1, 2025
Maintains: Buy
Price Target: $49 → $52
Current: $13.04
Upside: +298.77%
Jul 24, 2025
Initiates: Sell
Price Target: $7
Current: $17.88
Upside: -60.85%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $2.02
Upside: +345.54%
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $35.55
Upside: +54.71%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $14.91
Upside: +121.33%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $30.76
Upside: +88.56%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.70
Upside: +723.53%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $1.43
Upside: -16.08%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $1.45
Upside: +37.93%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $5.15
Upside: +55.34%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $2.84
Upside: -64.79%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $4.49
Upside: +679.51%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $20.18
Upside: +559.07%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $3.88
Upside: +312.37%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.34
Upside: +646.27%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $1.71
Upside: +603.81%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $6.75
Upside: -